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TGIF2LXBackground and study aims: Homeobox-containing genes are composed of a group of regulatory genes
encoding transcription factors involved in the control of developmental processes. The homeodomain
proteins could activate or repress the expression of downstream target genes. This study was conducted
to in vivo identify the potential target gene(s) of TGIF2LX in colorectal adenocarcinoma.
Methods: A human colorectal adenocarcinoma cell line, SW48, was transfected with the recombinant
pEGFPN1-TGIF2LX. The cells were injected subcutaneously into the flank of the three groups of
6-week-old female athymic C56BL/6 nude mice (n = 6 per group). The transcript profiles in the developed
tumours were investigated using the cDNA amplified fragment length polymorphism (cDNA-AFLP)
technique.
Results: The real-time RT-PCR and DNA sequencing data for the identified genes indicated that the
N-terminal domain-interacting receptor 1 (Nir1) gene was suppressed whereas Nir2 and fragile histidine
triad (FHIT) genes were upregulated followed by the overexpression of TGIF2LX gene.
Conclusion: Downregulation of Nir1 and upregulation of Nir2 and FHIT genes due to the overexpression
of TGIF2LX suggests that the gene plays an important role as a suppressor in colorectal adenocarcinoma.
 2018 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.Introduction
Homeobox genes contain a family of regulatory genes encoding
transcription factors with a role in the regulation of developmental
processes. This group of genes comprises a conserved sequence of
183 nucleotides, the homeobox, which encodes homeodomain, a60 amino acid helix-turn-helix type of DNA-binding motif [1,2].
Homeodomain proteins are greatly conserved in evolution and
are regularly found in animals, plants, and fungi. These proteins
have been reported to regulate various embryonic developmental
processes such as axis formation, limb development, and organo-
genesis [3]. A number of gene alterations in homeobox genes have
been established to be involved in diseases such as neuroblastoma,
leukaemia, and cancer [4–7]. Homeodomain proteins are catego-
rized into diverse classes on the basis of their sequences and con-
served domains [5]. The three-amino acid loop extension (TALE)
superclass consists of members contains three extra residues
between helix 1 and helix 2 of the homeodomain [8]. Some TALE
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clusters are involved in patterning along the anterior-posterior
body axis [9,10]. The TALE superclass is classified into four classes
in animals: PBC, MEIS, TGIF, and IRO (Iroquois) [4]. TG-interacting
factors (TGIFs) comprise a family of TALE-homeodomain proteins
that contains several members. Four TGIFs in human are TGIF,
TGIF2, TGIF2LX, and TGIF2LY (TGIF2 like on X or Y chromosomes).
Previous studies on cultured cells demonstrated that TGIF2 acts as
a transcriptional repressor and antagonizes TGF-beta-activated
gene expression [11,12]. Moreover, the tgif2 gene was found to
beamplified and over-expressed in various ovarian cancer cell lines
[13]. Whether and how it is implicated in the regulation of cell pro-
liferation and its molecular mechanism is not fully known. This
study was conducted to identify the possible target gene(s) of
TGIF2LX in colorectal adenocarcinoma using cDNA-AFLP, a gene
expression analysis assay that is not required prior to gene
sequencing.Table 1
Oligonucleotides used in this study.
Oligonucleotides Name Sequences
cDNA AFLP
Adaptors
and Primers
AdL EcoR 1 50-ACCGACGTCGACTATCCATGAAG-30
AdS EcoR 1 50-AATTCTTCATGG-30
Pre-EcoR 1 50-ACCGACGTCGACTATCCATGAAGAATTC-30
S1 EcoR 1 50-ACCGACGTCGACTATCCATGAAGAATTCC-30
S2 EcoR 1 50-ACCGACGTCGACTATCCATGAAGAATTCG-30
S3 EcoR 1 50-ACCGACGTCGACTATCCATGAAGAATTCA-30
S4 EcoR1 50-ACCGACGTCGACTATCCATGAAGAATTCT-30
Target Genes Nir1-F 50-TATCGGATCGCCAAGTTGCT-30
Nir1-R 50-TTGCAGAATCACCCCAAAGC-30
Nir2-F 50-GTAGAACTGAACATCGTGGCCG-30
Nir2-R 50-CCACATAGCCGTCTGACAGGA-30
FHIT-F 50-ATCATGGAGGCCATGGAACAC-30
FHIT-R 50-CATTCTTCAGCATGTGCGTGG-30
Housekeeping
Gene
GAPDH-F 50-CACCAGGGCTGCTTTTAAC-30
GAPDH-R 50-ATCTCGCCTCCTGGAAGAT-30Materials and methods
Cell culture
Human colorectal adenocarcinoma cell line, SW48, was
acquired from the National Cell Bank of Iran (NCBI) affiliated to
the Pasteur Institute (Tehran, Iran). The cell line was cultured in
RPMI-1640 medium (Gibco, Germany) supplemented with 5% fetal
bovine serum (FBS) (Gibco, Germany), 0.03% L-glutamine, 100
units/ml penicillin, 100 lg/ml streptomycin, and 250 ng/ml
amphotericin B (Gibco, Germany) at 37 C in a 5% CO2 atmosphere,
as previously described [14,15].
Cloning of TGIF2LX gene in an expression vector
After amplification of TGIF2LX coding sequence, the PCR pro-
duct was purified and cloned into pEGFP-N1, a eukaryotic expres-
sion vector. The recombinant pEGFPN1-TGIF2LX was transfected
into SW48 cells using X-tremeGENE siRNA Transfection Reagent
(Roche, Germany). An empty vector pEGFP-N1 was employed as
a mock control. Following 48 h, the transient transfection effi-
ciency was evaluated by a UV-fluorescent microscope (Olympus,
Japan). The transfected cells were next cultured in the presence
of 400 lg/ml G418 (Neomycin antibiotic) (Life Technology, Califor-
nia, USA) for 21 days to select the cells with overexpressing GFP (a
marker protein).
Animal study
An animal study was completed as previously explained [16].
Briefly, 6-week-old female athymic C56BL/6 nude mice (n = 6 per
group) were obtained from the Omid Institute for Advanced
Biomodels (Tehran, Iran). All animal experiments were conducted
according to to the Ethical Committee of Tehran University of Med-
ical Sciences (ethics code: ERC/S/277). After cell culture, 5  106
cells were transfected with the pEGFP-N1 (empty vector) and
pEGFP-TGIF2LX. The transfected cells and untransfected cells were
injected subcutaneously at a 200 ll volume of the serum-free med-
ium into the flank of the three groups of animals. After three weeks
and confirmation of tumour growth, the mice were anesthetized
and the tumours were completely isolated.
RNA extraction, Real-time RT-PCR and western blotting
Total RNA was extracted by TriZol isolation reagent (Invitrogen,
USA) according to the manufacturer’s instructions. Total RNA was
DNase-treated with DNase I)Invitrogen, USA) and 5 lg of totalRNA was used to synthesize cDNA fragments using random
sequence hexamer primers and Oligo(dT) with a cDNA synthesis
system kit (Vivantis, USA), following the manufacturer’s protocol.
The quality of cDNA was checked using the glyceraldehyde
3-phosphate dehydrogenase (GAPDH) RT- PCR.
Real-time RT-PCR was performed to verify the expression level
of TGIF2LX gene in colorectal adenocarcinoma cells. The reaction
mixture contained 1 ll of each primer (10 pmol/ll), 1 ll of cDNA
and 5 ll of 2  SYBR Green PCR Master Mix (SYBR Premix Ex Taq
II, Takara). The primers are listed in Table 1. The amplification plan
included an initial denaturation at 95 C for 10 min, followed by 45
cycles of a two-stage PCR consisting of 95 C for 10 s and 60 C for
30 s. Specificity of primers was verified by observing a single peak
in the dissociation curve for each run. All the reactions were done
in triplicate.
In order to evaluate the expression level of TGIF2LX protein,
Western blot analysis was conducted. Briefly, cell lysates for west-
ern blotting were prepared from SW48 cells transfected with the
pEGFP-N1 (empty vector), pEGFP-TGIF2LX transfected cells, and
untransfected cells. Afterward, SW48 cell lines were subjected to
10% SDS–PAGE electrophoresis and transferred to nitrocellulose
membrane (Amersham Biosciences, USA). The membranes were
blocked for 1 h with 3% Bovine Serum Albumin (BSA) at 37 C
and incubated with a 1:500 dilution of a polyclonal rabbit anti-
TGIFLX antiserum (Santa Cruz Biotechnology, Santa Cruz, USA)
for 2 h at room temperature. The membranes were incubated with
a goat HRP conjugated anti-rabbit IgG secondary antibody (1:5000)
for 1.5 h prior to the development with 4-chloro-1-naphthol (4CN)
(Immun-Blot, Bio-Rad Laboratories, USA).
Total RNA extraction and cDNA synthesis
Total RNA of tumours transfected with pEGFPN1-TGIF2LX and
empty vector was extracted by the TriZol isolation reagent (Invit-
rogen, USA) according to the manufacturer’s instruction. cDNA
was synthesized using 1 lg of total RNA, as described previously
[17,18].
cDNA amplified fragment length polymorphism (cDNA-AFLP)
The summary of the cDNA AFLP strategy is shown in Fig. 1. Dou-
ble strand cDNA (dscDNA) synthesis was carried out using DNA
polymerase I enzyme (Thermoscientific, USA) at 16 C for 2 h.
The synthesized dscDNA was purified and quantified by spec-
trophotometry and gel agarose electrophoresis and subjected to
restriction enzyme digestion. About 5 lg of dscDNA was digested
with 5 U EcoRI restriction enzyme (Fermentas, Burlington, Canada)
Fig. 1. A summary of steps involved in the cDNA-AFLP method.
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AFLP adaptors (Table 1) using T4 DNA ligase (Vivantis, USA) in T4
DNA ligase buffer in a final volume of 60 ll. Then, the pre-
amplification was carried out using pre-EcoRI primers (Table 1)
according to the following conditions: the first denaturation at
95 C for 5 min followed by 30 amplification cycles at 94 C forFig. 2. Fluorescence microscopic analysis of SW48 cell lines; (A): uninfecte40 s, 60 C for 40 s, and 72 C for 1.5 min, and a final extension at
72 C for 7 min.
The sensitive amplification was conducted as described using
sensitive amplification primers (Table 1). Sensitive amplification
products were separated on 10% non-denaturing polyacrylamide
gel electrophoresis (PAGE) and stained with silver nitrate. Finally,
the polyacrylamide gel was evaluated for the presence of
expressed transcription-derived fragments (TDFs).
Isolation, cloning, and sequence analysis of TDFs
Differentiated TDFs were separated from the polyacrylamide gel
and the eluted DNA was re-amplified by appropriate sensitive pri-
mers. The PCR products were checked using 1.5% agarose gel elec-
trophoresis and subsequently cloned into a pTZ57R/T Vector
(Thermo scientific, USA). The recombinant plasmids containing
unknown DNA were sequenced using M13 forward and reverse
primers to determine the identity of the isolated TDFs. Data from
sequencing were analyzed in non-redundant nucleic and protein
databases Basic Local Alignment Search Tool (BLAST) (http;//
www.ncbi.nim.nih.gov/BLAST).
Real-time RT-PCR analysis
Real-time RT-PCR was carried out to confirm the differences in
expression patterns of TDF-derived genes. Target gene primers
were designed by NCBI primer-BLAST program (http;//www.ncbi.
nim.nih.gov/BLAST) based on the identified genes (Table 1). In
order to evaluate the relative gene expression, real-time PCR was
performed in triplicate using a CFX96TM Real-Time System
(C1000TM Thermal Cycler) (Bio-Rad, Hercules, CA, USA). Reaction
mixtures contained 2 ll cDNA, 10 ll of SYBR Green I Taq Mix
(Takara, Dalian, China), 1 ll (0.2 mM) of each primer, and 6 ll
ddH2O in a total volume of 20 ll. The amplification condition
was as follows: initial denaturation at 95 C for 3 min, followed
by 45 amplification cycles consisting of 95 C for 5 s, and 60 C
for 20 s. The GAPDH gene was used as a housekeeping gene to
normalize the data. The relative expression level of the aforemen-
tioned gene was analyzed by comparing the cycle thresholds (CTs)
of the target genes with GAPDH using the 2DDCT method [19].
Results
TGIFLX expression in human colorectal adenocarcinoma (SW48) cell
lines
After a 48 h post-infection of SW48 cells with recombinant
pEGFPN1-TGIF2LX, pEGFP-N1 (empty vector), and untransfected
cells, the cells were examined by UV-fluorescent microscopy
(Fig. 2).d cells without fluorescence, (B): pEGFP-N1 and C: pEGFPN1-TGIF2LX.
Fig. 3. The mice with the colorectal adenocarcinoma tumour at 21 days of post
injection of cells.
Fig. 5. A representative illustration of cDNA-AFLP on PAGE. Sensitive amplification
of cDNA-AFLP on a PAGE from four different primer combinations: S1/S2 EcoRI, S1/
S3 EcoRI, S2/S3 EcoRI, S3/S4 EcoRI and S4/S4 EcoRI. The arrows show differentially
expressed TDFs. M; (100 bp) molecular size marker.
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pEGFP-N1 (empty vector), and untransfected cells into the flank of
nude mice, tumour tissues were exactly isolated using a stereomi-
croscope (Fig. 3). There was no significant difference between
transfected and non-transfected tumours in visible size.
After confirmation of colorectal adenocarcinoma tumour by his-
tological analysis, transcription and translation of TGIF2LX in
tumour cells transfected with pEGFPN1-TGIF2LX were confirmed
using quantitative RT-PCR and western blotting, respectively
(Fig. 4).
Analysis of the cDNA-AFLP products
The cDNA-AFLP products were separated on 10% non-
denaturing PAGE and visualized by silver staining (Fig. 5). Several
bands containing TDFs were excised from PAGE, then extracted
and re-amplified. Afterward, each desirable band was sub-cloned
into TA-cloning vector. After DNA sequencing and analyzing by
BLAST, three target genes, including NIR1, NIR2, and FHIT were rec-
ognized, which were differentially expressed in the studied
samples.Fig. 4. Expression of TGIF2LX gene in colorectal tumour cells. (A): RT- PCR result with sp
100 bp size marker (B): Western blotting assay shows significant over expression of TGIF2
N (lane2) cells.Validation of cDNA-AFLP results by Real-time PCR
Real-time RT-PCR was carried out to confirm the differential
expression of target genes in the tumour cells transfected with
the pEGFPN1-TGIF2LX and empty vector. The qRT-PCR resultsecific TGIF2LX primers. Lane 1: SW48; lane 2: SW48-N; lane 3: SW48-X and lane M:
LX (53.5KDa) in SW48-X cells (lane 3) in comparison with SW48 (lane 1) and SW48-
Fig. 6. Relative gene expression pattern of target genes in the cells with and
without TGIF2LX by real time RT-PCR. The expression of GAPDH was performed to
normalize the data. The values are the mean ± SD of three independent experiments
(P < 0.05).
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and down-regulation of Nir1 5-fold in cells transfected with
pEGFPN1-TGIF2LX compared to cells with empty vector (P < 0.05)
(Fig. 6).
Discussion
Colorectal cancer (CRC) is the third most prevalent cancer in
men and second most common malignancy in women worldwide
[20–22]. CRC is also the third leading cause of cancer-related death,
with approximately 600,000 cases annually [23]. Recently, thera-
peutic strategies for solid tumour treatment have been focused
on targeting specified cellular signaling pathways [24,25] that con-
trol cell proliferation, apoptosis, and angiogenesis. One of the
important signaling pathways in CRC is the transforming growth
factor-beta (TGF-b) signaling pathway [26].
TGIF, as a co-repressor for TGF-b-activated Smads, has been
revealed to actively repress TGF-b/Smad target genes such as
P15, P21, and P27 [27–29]. TGIF plays an important role in holo-
prosencephaly and ovarian cancer. TGIF2 has been demonstrated
to be effective in the progression of ovarian tumours via promoting
gene amplification and upregulation of key oncogenic proteins
[13,30].
This study was carried out to investigate and identify down-
stream genes regulated by TGIF2LX. Our hypothesis was that
TGIF2LX, like the majority of homeobox genes, could activate or
repress downstream target gene(s) directly or indirectly. According
to the results, the ectopic expression of TGIF2LX in SW48 cell line
resulted in the downregulation and upregulation of Nir1 and Nir2
expression, respectively.
N-terminal domain-interacting receptor 1 (Nir1), or membrane-
associated phosphatidylinositol transfer protein 3, PITPNM3 (also
named PYK2), is located on chromosome 17p13.1. This gene con-
tains 20 exons spanning approximately 101 kb of genomic
sequence that encodes a protein belonging to phosphatidyl-
inositol transfer protein (PITP) family [30,31]. Nir1 is a receptor
for CCL18 in cellular membrane of cancer cells. The CCL18 specifi-
cally binds to Nir1 to promote migration and metastasis of cancercells, especially in breast cancer. In an experimental study, Zhang
et al. investigated the correlation of Nir1 expression with the clin-
icopathological features of breast cancer patients and the effect of
Nir1 expression on the cell migration and invasion [32]. It was
shown that Nir1could promote invasion and chemotaxis of cancer
cells by binding to CCL18. Nir1potentially involves in cofilin recy-
cling and actin polymerization via binding to CCL18. These
researchers found that Nir1 could induce epithelial-mesenchymal
transition (EMT) via the PI3K/Akt/GSK3b/Snail signaling pathway
through binding to CCL18. Accordingly, Nir-1 could have a biolog-
ical role in cancer initiation and progression. Also, this gene poten-
tially involves in cell migration and invasion-related signaling
pathways [32]. The human Nir2 (also known as H-rdgB) is a
domain known to contain several retinopathy loci, including Best
disease and Bardet-Biedl syndrome I [32].
Moreover, Thian et al. showed that Nir2 as a novel regulator of
the small GTPase Rho plays an important role in actin cytoskeleton
reorganization and cell morphogenesis of neuronal cells [32]. It has
been revealed that blocking of NIR2 function by microinjection of
antibodies against protein NIR2 results in the production of mult-
inucleate cell formation. The Nir-2-related genes and correspond-
ing signaling pathways have been revealed to enhance EMT
in vitro and metastasis in animal models. Also, the upregulation
of this gene was shown to contribute to cancer development and
progression [32,33].
In the present study, Nir2 as a TGIF2LX target gene, was upreg-
ulated in colorectal adenocarcinoma, grade 4, which resulted in an
increase in tissue differentiation and a reduction of oncogenesis.
Also, downregulation of Nir1 and upregulation of Nir2 caused by
TGIF2LX overexpression in SW48 cells suggested that TGIF2LX
might suppress tumourigenesis. The results also demonstrated an
overexpression of Fhit gene in SW48 colorectal adenocarcinoma
cells transfected with TGIF2LX, indicating it as a potential target
gene. The Fhit at human chromosome 3p14.2 is a candidate tumour
suppressor gene. Some studies have shown that the reduction of
Fhit is a triggering factor in carcinogenesis of some malignancies,
including lung, esophageal, and liver cancers. The FHIT gene
belongs to the histidine triad superfamily and encodes a cytoplas-
mic protein with a hydrolase activity. The fragility of this gene may
make it susceptible to rearrangements or carcinogenesis-induced
alterations. In other words, the degree of chromosomal fragility
may determine the degree of cancer susceptibility [33–37].
Although the detailed mechanism of Fhit action is not fully under-
stood, the role of Fhit as a tumour suppressive gene has been con-
firmed in cancerous cells [38]. At the cellular level, Fhit has been
indicated to promote apoptosis and retard tumour cell prolifera-
tion in vitro and in vivo [39].In the present study, the upregulation
of Fhit gene in transfected SW48 indicates the potential role of
TGIF2LX in suppression of tumour cells. Based on these data, it
can be concluded that TGIF2LX may function as an imperative sup-
pressor colorectal adenocarcinoma cellbased on alteration the tar-
get genes (Nir1, Nir2, and Fhit), as potential mediators in
carcinogenesis. To the best of our knowledge, this is the first report
that proposes Nir1, Nir2, and Fhit genes might be regulated by
homeodomain protein TGIF2LX in colorectal adenocarcinoma cells.
These results may provide a new insight into the multiple cancer
signaling pathways underlying colorectal cancer development. It
looks promising to use this protein for modulating signals medi-
ated oxidative and degenerative damages. However, further inves-
tigations are required to find the precise biological functions of the
TGIF2LX gene in cancer cells.Conflicts of interest
None declared.
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